Fig. 2From: The short-term outcomes of pulmonary metastasectomy or stereotactic body radiation therapy for pulmonary metastasis from epithelial tumorsThe 3-year overall survival rates of the PM and SBRT groups. The 3-year overall survival rates of the PM and SBRT groups were 77 and 52%, respectively, and did not differ to a statistically significant extent (p = 0.10)Back to article page